INTRODUCTION
============

Gene expression in *Escherichia coli* and its phage can be controlled at the level of transcription termination. The best-studied examples of this mechanism are the ribosomal operons (*rrn*) and the bacteriophage λ ([@B1; @B2; @B3]). Transcription of the *E. coli rrn* operons is in part regulated by suppression of termination (anti-termination) ([@B4]). Anti-termination in *rrn* is mediated by an RNA recognition sequence (AT) located just distal to the promoters, close to the 5′ end of the pre-rRNA transcript ([Figure 1](#F1){ref-type="fig"}A). A number of factors, including NusA, NusB, NusE (ribosomal protein S10) and NusG, modify RNA polymerase (RNAP) at AT. The modified RNAP is insensitive to termination by Rho-dependent terminators that occur throughout the long pre-rRNA transcript. AT includes a highly conserved sequence (*boxA*) that binds NusB, NusE and NusB--NusE complex ([@B5],[@B6]). Distal to AT is an additional conserved sequence (*boxC*) that is less well characterized, but is a specific binding site for NusA in *Mycobacterium tuberculosis rrn* ([@B7]). Two short oligo ribonucleotides derived from the *boxC* stem--loop motif bind exclusively to the two KH domains of NusA in a completely extended conformation, and adenine-backbone interactions with the trinucleotide sequence AUA are particularly critical for this interaction ([@B8]). Figure 1.Different anti-terminator signal sequences. (**A**) *rrn*G leader sequence of *E. coli*. *boxB*, *boxA* and *boxC* refer to the λ-like anti-terminator (AT) features. Each box sequence is numbered separately; *boxA* and *boxC* are underlined. (**B**) Phage λ *nut* anti-termination sequence. λ*nutR* and λ*nutL* differ in the sequence and length of the *spacer* between *boxA* and *boxB*, as well as position 9 in the loop region of *boxB*. (**C**) Domain order of *E. coli* NusA. The numbers show the boarders of the six domains: N-terminal domain (NTD), S1 domain (S1), K-homologous domain (KH), acidic repeat (AR).

Gene expression in lambdoid phages is also controlled by anti-termination. The Nus proteins form a complex with and modify RNAP at the λ*nutL* and *nutR* sequences. *nutL* and *nutR* consist of *boxA*, a *spacer*, a stem--loop element (*boxB*), and *boxC* ([Figure 1](#F1){ref-type="fig"}B). The *rrn boxA* (5′-UGCUCUUUA-3′) and the λ *boxA* (5′-CGCUCUUA-3′) differ; the CUUUA of *rrn boxA* is thought to enhance anti-termination efficiency ([@B9]). λ and other lambdoid phages express N, an RNA-binding protein of the arginine-rich motif (ARM) family, that binds *boxB* ([@B10; @B11; @B12; @B13]). N is required for anti-termination on the λ chromosome. ([@B14]). In both the *rrn* and λ anti-termination systems, the modified RNAP retains the ability to transcribe through multiple terminators. However, *rrn* anti-termination is effective only at Rho-dependent terminators, whereas λ anti-termination complexes are highly resistant to both Rho-dependent and Rho-independent terminators ([@B15]).

The *nut* sequences and the Nus factors are also utilized by the phage HK022 Nun protein, an ARM protein related to N, to arrest transcription on the λ chromosome ([@B11],[@B16],[@B17]).

NusA is essential in wild-type *E. coli* ([@B18],[@B19]) but not in *E. coli* deleted for cryptic prophage ([@B20]). In addition to promoting anti-termination, it enhances RNAP pausing ([@B21],[@B22]) and termination ([@B23],[@B24]). These reactions may be promoted by contacts between NusA and the 3′OH end of nascent RNA ([@B25]). NusA consists of five functional subdomains: an N-terminal domain that interacts with RNAP ([@B26]), three RNA-binding domains, S1, KH1 and KH2 ([@B8],[@B27],[@B28]) and two C-terminal acidic domains, AR1 and AR2, that interact with λ N and the α subunit of RNAP, respectively ([Figure 1](#F1){ref-type="fig"}C) ([@B17],[@B29],[@B30]). AR2 masks one or more of the RNA-binding domains, thereby preventing NusA interaction with RNA ([@B31]). Structures of homologous NusA proteins from *Thermotoga maritima* (*T. maritima*) and from *M. tuberculosis* were determined in the absence and presence of RNA, respectively. Both structures show NusA to be highly elongated ([@B8],[@B27],[@B28]). Although knowledge of NusA has increased in recent years, several key questions are still open: Does *E. coli* NusA bind specifically or non-specifically to RNA? What *rrn* or *nut* sequences are critical for NusA binding? Are there structural differences between the NusA-*rrn* and NusA--*nut* RNA complexes?

MATERIALS AND METHODS
=====================

Buffers and reagents
--------------------

All fluorescence titrations were performed in 50 mM potassium phosphate, 100 mM NaCl, 10 mM β-mercaptoethanol, pH 7.6, unless otherwise stated. Oligodeoxynucleotides as well as fluorescently-labeled oligoribonucleotides were obtained from biomers.net (Ulm, Germany; [Table 1](#T1){ref-type="table"}) and used according to the manufacturer\'s instructions. Table 1.3′6-carboxyfluorescein (6-Fam)-labeled RNA oligonucleotides used in this studyOligonucleotideSequence*K*~d~ for NusA--SKK (µM)*nutR boxA*-*spacer*5′-**cgcucuua***cacauucca*-3′126 ± 4*nutL boxA*-*spacer*5′-**cgcucuua***aaaauuaa*-3′71 ± 4*rrn cac*-*boxA*-*spacer*5′-CAC**ugcucuuua***acaauuua*-3′14 ± 0.2*nutR boxA*5′-**cgcucuua**-3′n.d.*nutR spacer*5′-*cacauucca*-3′137 ± 17*nutL spacer*5′-*aaaauuaa*-3′24 ± 2.2*nutR boxA5*-*spacer*5′-**c[u]{.ul}cucuu***acacauucca*-3′124 ± 7*nutR boxA16*-*spacer*5′-**cgcu[a]{.ul}uua***cacauucca*-3′106 ± 4*nutR boxA69*-*spacer*5′-**[auagcggc]{.ul}***cacauucca*-3′n.d.*nutL boxA*-*spacer* (*mut*)5′-**cgcucuua***aaaa[gg]{.ul}aa*-3′n.d.*rrn boxA*5′-**ugcucuuua**-3′194 ± 38*rrn-upstream-boxA'* (I)5′-CAC**ugcuc**-3′26 ± 0.8*rrn*-*upstream* (II)5′-AGCGGCAC-3′30 ± 1.9*rrn spacer* (III)5′-*acaauuua*-3′71 ± 3.3*nutR boxB*5′-agcccugaaaaagggc-3′n.d.[^1]

Plasmid construct, expression and protein purification
------------------------------------------------------

The DNA sequence of the NusA RNA-binding domains from amino acid 132 to 348 (NusA--SKK) was cloned via the BamHI and NdeI restriction sites into the *E. coli* expression vector pET11a (Novagen). The soluble recombinant NusA-SKK protein contained an N-terminal 5×His tag. NusA-SKK was expressed and purified according to published procedures ([@B31]). Briefly, *E. coli* strain BL21 (DE3) (Novagen) harboring the recombinant plasmid was grown at 37°C in LB medium (Luria-Bertani) containing ampicillin (100 µg/ml) until OD~600~ = 0.5 and then induced with 0.1 mM isopropyl 1-thio-β-[d]{.smallcaps}-galactopyranoside (IPTG). Cells were harvested 4 h after induction, lysed and purified as described ([@B31]). Finally, the protein was dialyzed against buffer as used for fluorescence measurements. The dialyzed protein was concentrated with Vivaspin concentrators (Vivascience, MWCO 10 000 Da). The identity and structural integrity of purified protein was analyzed by 19% SDS--PAGE as well as by CD- and NMR spectroscopy.

NMR spectroscopy
----------------

NMR spectra were recorded on Bruker DRX 600 MHz spectrometers with triple-resonance probes equipped with pulsed field-gradient capabilities. The sample temperature was 298 K. 1D ^1^H spectra were collected with water suppression using a 1-1 spin-echo pulse sequence including gradients.

Fluorescence equilibrium measurements
-------------------------------------

We used various RNA sequences corresponding to λ *nut* to *rrnG boxA* sequence (*rrn BoxA*) of the *E. coli* genome ([Table 1](#T1){ref-type="table"}). Fluorescence equilibrium titrations were performed using an L-format Jobin-Yvon Horiba Fluoromax fluorimeter equipped with an automatic titration device (Hamilton). Extrinsic fluorescence measurements with 3′ 6-carboxy-fluorescein (6-FAM)-labeled RNA were performed in fluorescence buffer as above in a total volume of 1 ml using a 10 × 4 mm quartz cuvette (Hellma GmbH, Mühlheim, Germany). The excitation wavelength was 492 nm, and the emission intensity was measured at 516 nm applying a 500 nm cutoff filter. For anisotropic measurements, slit widths were set at 4.5 nm and 3.5 nm for excitation and emission, respectively. All titration measurements were performed at 25°C with 50 nM of fluorescently-labeled RNA. Following sample equilibration, at least six data points with an integration time of 0.8 s were collected for each titration point in the case of anisotropic measurements.

Data fitting
------------

Isotropic as well as anisotropic data were fitted to a two-state binding equation to determine the equilibrium dissociation constant (*K*~d~) using standard software. The anisotropy was calculated from: where *A*, *A*~complex~ and *A*~RNA~ are the anisotropy values and *f*~complex~, *f*~RNA~ are the fractional intensities. The change in fluorescence intensity has to be taken into account, so that the bound fraction is given by with where *A* is the anisotropy; *A*~RNA~ is the initial free anisotropy, *A*~complex~ is the anisotropy of the protein--RNA complex and P~0~ and RNA~0~ represent the total protein and RNA concentrations, respectively. *R* is the ratio of intensities of the bound and free forms.

RESULTS
=======

The *E. coli* NusA protein includes a C-terminal domain that masks the RNA-binding region ([@B17],[@B26],[@B29],[@B31]). To determine the interaction of *E. coli* NusA with different RNA substrates, we used a NusA construct (NusA--SKK) lacking the two acidic-repeat C-terminal domains AR1 and AR2, as well as the N-terminal domain ([Figure 1](#F1){ref-type="fig"}C). These regions are not directly involved in RNA binding. Thus, *E. coli* NusA416, deleted for AR2, forms complexes with the *rrnG* leader region as well as with the *M. tuberculosis nut* RNA. Electrophoretic mobility-shift assays (EMSAs) showed that the truncated *E. coli* NusA protein bound *nut*-like RNA species with high affinity, whereas the specificity was significantly lower than that of the *M. tuberculosis* NusA ([@B7]). This prompted us to investigate the affinity of different RNA species to *E. coli* NusA using fluorescence measurements. To avoid possible false negatives due to protein binding too distal to the fluorescence dye to alter fluorescence signal intensity, we used anisotropic fluorescence titrations instead of isotropic fluorescence measurements. Fluorescence anisotropy can detect molecular interactions even when an isotropic fluorescence signal change is weak or absent ([@B32]). Furthermore, changes of the fluorophore environment can be neglected with anisotropic measurements since the results are related to the rotational correlation time of a macromolecule with a rigidly attached fluorophore ([@B33]).

An extended *rrn boxA* sequence has the highest affinity to NusA--SKK
---------------------------------------------------------------------

We first turned our attention to three different RNA species, the *rrnG* anti-terminator region, λ*nutL* and λ *nutR*, all of which interact with NusA and the other Nus factors ([@B4]). *rrn* carries a stem--loop structure (*boxB*), *boxA* and *boxC* sequences. The *boxB* and *boxC* sequences of *rrn* are not required for anti-termination ([@B1]).

The *boxA* sequence of *rrn* differs from that of λ at the initial base and by the insertion of an additional U residue at the penultimate site, converting the *rrn boxA* to a consensus site. Conversion of λ*box*A to consensus enhances N activity ([@B34]). The *spacer* sequence of *rrn* differs from both λ*nutL* and λ*nutR*, but all three *spacers* carry a conserved sequence of AUU ([Figure 1](#F1){ref-type="fig"}). Interestingly, we find that the *rrn cac*-*box*A-*spacer* sequence, which includes a CAC sequence just upstream to *boxA*, binds with higher affinity to NusA--SKK (*K*~d~ = 14 µM; [Figure 2](#F2){ref-type="fig"}; [Table 1](#T1){ref-type="table"}) than either the λ*nutR boxA-spacer* (126 µM) or the λ*nutL boxA-spacer* (71 µM; [Figure 2](#F2){ref-type="fig"}; [Table 1](#T1){ref-type="table"}). Figure 2.Fluorescence anisotropy measurements with homologous nut-RNAs. 50 nM *rrn boxA-spacer* (filled square), λ*nut*R *box*A-*spacer* (filled circles), λ*nutL boxA*-*spacer* (filled triangles) and λ*nutR boxB* (open triangles) were titrated with NusA--SKK. The extrinsic fluorescence of the 3′ 6-FAM label of the RNAs was determined. The curves show the best fit to Equation ([@B3]) (see 'Materials and Methods' section). *K*~d~ values of 14 µM, 126 µM, 71 µM were determined, respectively (solid line; see [Table 1](#T1){ref-type="table"}). No *K*~d~ values could be fitted to λ*nutR boxB*.

Role of *boxA* flanking sequences in binding of NusA--SKK
---------------------------------------------------------

In these experiments, we tested *boxA* sequences with flanking regions ([Table 1](#T1){ref-type="table"}). In the case of *rrn*, these included sequences between *boxB* and *boxA* (in capital letter), as well as sequences between *boxA* and *boxC* (*spacer*, in italics). In the case of phage λ*nutL* and λ*nutR*, the *spacer* separates *boxA* from *boxB*. We proceeded to further define the NusA--SKK interaction regions at λ*nutR*, λ*nutL* and *rrn*.

In the case of the λ*nut* sites, we find that the λ*nutL spacer* binds to NusA--SKK (24 µM), whereas *boxA* alone shows no association with the protein ([Figure 3](#F3){ref-type="fig"}A). Similarly, the *nutR spacer* binds NusA-SKK with an affinity nearly identical to that of *nutR boxA-spacer* (*K*~d~ value ∼137 µM; [Figure 3](#F3){ref-type="fig"}B), whereas NusA--SKK binding to *box*A could not be detected. Figure 3.Fluorescence anisotropy measurements with seperated RNAs regions. In each titration 50 nM of 6-FAM-labeled RNA was used. (**A**) 50 nM of 6-FAM-labeled λ*nutL boxA-spacer* (squares), λ*nutL spacer* (circles), λ*nutL boxA* (triangles) were titrated with NusA-SKK. *K*~d~ values of 71 µM and 24 µM were determined for λ*nutL boxA*-*spacer*, λ*nutL spacer*, respectively (solid lines). No *K*~d~ value could be fitted to λ*nutL boxA* (see [Table 1](#T1){ref-type="table"}). (**B**) 50 nM of 6-FAM-labeled λ*nutR box*A-*spacer* (circles), λ*nutR spacer* (squares), λ*nutR boxA* (triangles) were titrated with NusA-SKK. *K*~d~ values of 126 µM and 137 µM were determined for λ*nutR boxA*-*spacer*, λ*nutR spacer*, respectively (solid lines). No *K*~d~ value could be fitted to λ*nutR boxA* (see [Table 1](#T1){ref-type="table"}). (**C**) 50 nM of 6-FAM-labeled *rrn box*A alone (open triangle), *rrn cac-boxA-spacer* (open square), *rrn spacer I* (open circle), *rrn spacer II* (filled circle), *rrn spacer III* (filled triangle) were titrated with NusA-SKK. *K*~d~ values can be seen in [Table 1](#T1){ref-type="table"}. No *K*~d~ value could be fitted to *rrn boxA* (see [Table 1](#T1){ref-type="table"}).

To validate this result, we analyzed *nutR boxA-spacer* sequences with mutations in the *boxA* region ([@B34],[@B35]). The *boxA5* and *boxA16* mutations decrease N activity, whereas the *boxA69* mutation has little effect on anti-termination ([@B36]). Fluorescence titrations of the three mutant RNAs indicate that only *boxA69* significantly increased the *K*~d~ value (\>200 µM) for NusA--SKK complex formation, whereas *boxA5* and *boxA16* exhibited *K*~d~ values similar to that of wild-type *boxA* (∼120 µM; [Figure 4](#F4){ref-type="fig"}A). These data demonstrate that *boxA* mutations that affect anti-termination have a very limited effect on NusA--SKK binding. Their phenotype instead may reflect a failure to bind NusB ([@B37]). Why λ*nutR boxA69-spacer* binds NusA--SKK less efficiently than λ*nutR spacer* alone is unclear, although a similar result was reported by Mah *et al*. ([@B31]) for a λ*nut* containing a reversed *boxA*. Furthermore, we also tested a mutation in the λ*nutL spacer* that replaces residues U13 and U14 that are conserved at both λ*nutR* and λ*nutL* ([Figure 1](#F1){ref-type="fig"}B). This conservation suggests that these bases are important for binding of interaction partners. Indeed, transversion of these residues to G completely abolished NusA binding to *nutL-spacer* ([Figure 4](#F4){ref-type="fig"}B). Figure 4.Fluorescence anisotropy measurements with mutated λ*nut boxA* RNA. (**A**) 50 nM of 6-FAM-labeled λ*nut*R *box*A-*spacer* (circles), λ*nut*R *boxA5*-*spacer* (squares), λ*nut*R *boxA16-spacer* (triangles), or λ*nut*R *boxA69-spacer* (diamonds) were titrated with NusA-SKK. *K*~d~ values of 126 µM, 124 µM, 106 µM were determined, respectively (solid lines; see [Table 1](#T1){ref-type="table"}). No *K*~d~ values could be fitted to λ*nutR boxA69* (see [Table 1](#T1){ref-type="table"}). (**B**) 50 nM of 6-FAM-labeled λ*nutL boxA-spacer* (circles), λ*nutL* mut. *spacer* (squares) were titrated with NusA-SKK. *K*~d~ value of 71 µM was determined for *nutL box*A-*spacer* (solid lines). No *K*~d~ value could be fitted to *nutL boxA-mut- spacer* (see [Table 1](#T1){ref-type="table"}).

We extended our analysis to the *rrn* anti-termination region, examining the binding affinities of RNA sequences upstream and downstream to *boxA* as well as *boxA* itself ([Table 1](#T1){ref-type="table"}). First, we found that *rrn boxA* showed no binding to NusA--SKK ([Table 1](#T1){ref-type="table"}). However, RNA that included an upstream CAC, as well as the first five bases of *boxA* was bound with high affinity (26 ± 0.8 μM), as was the 8 bases upstream of *boxA* (AGCGGCAC, 30 ± 1.9 μM; [Figure 3](#F3){ref-type="fig"}C). The *rrn spacer* also bound NusA-SKK with an affinity intermediate between that of λ*nutR spacer* and λ*nutL spacer* (71 ± 3.3 μM). Alignment with ClustalW2 of *rrn*, λ*nutL*, and λ*nutR* shows a conserved sequence, 5′-auu-3′, in all three *spacers*.

λ*boxB* does not interact with NusA--SKK
----------------------------------------

In contrast to *boxA* and flanking sequences, titration of λ*nutR boxB* with NusA-SKK, showed no, or only very weak, nonspecific protein--RNA interactions ([Figure 5](#F5){ref-type="fig"}). To confirm that λ*nutR boxB* does not interact with NusA-SKK, even at higher concentrations, we analyzed a sample containing both species with 1D-NMR. In contrast to λ*nutR boxA*, λ*nutR boxB* forms a stable stem--loop structure allowing the detection of the slowly exchanging imino protons in the double-stranded stem region. The 1D-NMR spectrum of NusA-SKK in the absence of RNA shows a well-dispersed amide proton signal region, indicating a stably folded, highly structured protein ([Figure 5](#F5){ref-type="fig"}A). The λ*nutR boxB* 1D-NMR spectrum reveals signals in the range of 12--14 p.p.m., corresponding to the imino protons of the stem region ([Figure 5](#F5){ref-type="fig"}B). Interaction between the stem region of λ*nutR boxB* and NusA--SKK, would affect these readily observable imino proton signals. The observable signals, however, of both protein and RNA, were unchanged when incubated together, clearly indicating that no complex forms between NusA--SKK and λ*nutR boxB* even at NusA concentrations in the high micromolar range ([Figure 5](#F5){ref-type="fig"}C). The observed signal increase is due to the lower concentration of λ*nutR* RNA after addition of NusA--SKK. Figure 5.1D-NMR analysis. Imino proton region of NusA--SKK (175 µM; **A**), *nut*R *box*B (100 µM; **B**) and NusA-SKK+*λnutR boxB* (3:1; **C**).

CONCLUSIONS
===========

Mutational studies indicated that NusA as well as *boxA* play an important role in anti-termination ([@B38],[@B39]). *boxA* forms a complex with NusB/NusE ([@B5],[@B6],[@B37]) and it was suggested that NusA links λ*nut boxA* and λ*nut boxB* by binding to both ([@B37],[@B40]). Oddly, however, and in contrast to *boxA* point mutations, anti-termination was still efficient, and NusB-independent, in a *boxA* deletion mutant ([@B36],[@B41]). Additionally, deletion of the initial three bases (cac) of the λ*nutR spacer* did not affect anti-termination, whereas deletion of the initial six bases (cacauu) led to complete loss of anti-termination activity. In agreement with the X-ray structure of *M. tuberculosis* NusA with RNA and deletion studies, our fluorescence analyses revealed that NusA recognizes a *spacer* sequence that includes the critical bases AUU ([@B8],[@B36]). NusA interaction with the *rrn*, λ*nutL* and λ*nutR boxA*-*spacer* motif was demonstrated by mutational studies and *in vitro* binding assays ([@B1],[@B37],[@B39],[@B42]), and NusA was also suggested to recognize RNA outside the λ*nut* region ([@B19],[@B27],[@B37],[@B43]). Complex formation between NusA and *spacer* might promote binding of NusE/NusB to the adjacent *boxA* sequence, and the notion that NusA binds to the λ*nut spacer* region is now strongly supported by the present fluorescence titration data.

Differences between the *rrn* anti-terminator regions and λ*nut* have already been described ([@B5],[@B37]). Berg *et al*. ([@B1]) showed that *rrn boxA-spacer* plus seven upstream residues were sufficient to suppress termination at Rho-dependent terminators. We show here that the upstream CAC sequence as well as the downstream *spacer*, bind NusA--SKK. This redundancy may be related to the fact that λ*nut*-dependent anti-termination, which suppresses both Rho-dependent and Rho-independent terminators, requires λN and *boxB*, whereas *rrn* anti-termination requires neither ([@B37],[@B44]). In addition to greater anti-termination efficiency, the requirement for λN and BoxB allows regulation of λ anti-termination. Thus, λ N levels are controlled at the levels of transcription, translation and protein stability ([@B45],[@B46]).

Note that the NusE/NusB complex binds to *boxA* with affinities in the nanomolar range ([@B5]), whereas the *K*~d~ values for NusA--SKK are in the micromolar range. We suggest that tight RNA binding by NusA may not be required since it is already bound to RNAP and thus in close vicinity to nascent RNA. The λ*nutL spacer* sequence differs from that of λ*nutR spacer* ([Table 1](#T1){ref-type="table"}), and this difference is thought to account in part for the enhanced efficiency of Nun-mediated termination at λ*nutL* relative to λ*nutR* (Washburn, R.S. and Gottesman,M.E., unpublished data), and λ*nutL boxA-spacer* binds with significantly higher affinity to NusA--SKK than does λ*nutR boxA-spacer*. Both *spacer* sequences contain U\'s at residues 13 and 14, implying that these bases are important interaction partners. As shown above, replacement of the U\'s with G\'s completely abolished NusA--SKK binding to λ*nutL-spacer*. From this and other data, the following picture of the assembly of the anti-termination complex at the λ*nut* RNA has evolved ([Figure 6](#F6){ref-type="fig"}): After RNAP has synthesized λ*nut* RNA, NusE and NusB bind to *boxA*, and NusA binds to *spacer* facilitated by NusA AR2 interaction with the C-terminal domain of the α subunit of RNAP. λN protein binds to AR1 of NusA as demonstrated for N(34-47) (17,30), forming a weak helix at the protein\'s N-terminus ([@B17]). This weak helix facilitates recognition of *boxB* ([@B17]). NusA interaction with RNA is thus stabilized by the AR2:RNAP interaction as well as by the AR1:N:*boxB* interaction, relieving the requirement for tight binding of NusA to λ*nut*. Figure 6.Model of the anti-termination network. The interaction of the RNAP with various factors important for anti-termination (see text for details).
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[^1]: *boxA* nucleotides are shown in bold. Mutated nucleotides are underlined. Flanking regions of *rrn-boxA* are in capital letters. The *spacer* is shown in italic.
